
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Overcoming the immune suppressive nature of glioblastoma by leveraging the surgical intervention - current status and future perspectives
Johnny Duerinck, Sandra Tuyaerts, Kiavash Movahedi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Johnny Duerinck, Sandra Tuyaerts, Kiavash Movahedi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Showing 6 citing articles:
The need for paradigm shift: prognostic significance and implications of standard therapy-related systemic immunosuppression in glioblastoma for immunotherapy and oncolytic virotherapy
Aleksei A. Stepanenko, Anastasiia O. Sosnovtseva, M. P. Valikhov, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Aleksei A. Stepanenko, Anastasiia O. Sosnovtseva, M. P. Valikhov, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Tumor-associated microenvironment, PD-L1 expression and their relationship with immunotherapy in glioblastoma, IDH-wild type: A comprehensive review with emphasis on the implications for neuropathologists
Giuseppe Broggi, Giuseppe Angelico, Jessica Farina, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155144-155144
Open Access | Times Cited: 6
Giuseppe Broggi, Giuseppe Angelico, Jessica Farina, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155144-155144
Open Access | Times Cited: 6
Preclinical evaluation of antigen-sensitive B7-H3-targeting nanobody-based CAR-T cells in glioblastoma cautions for on-target, off-tumor toxicity
Fien Meeus, Cyprine Neba Funeh, Robin Maximilian Awad, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 11, pp. e009110-e009110
Open Access | Times Cited: 1
Fien Meeus, Cyprine Neba Funeh, Robin Maximilian Awad, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 11, pp. e009110-e009110
Open Access | Times Cited: 1
Optimal control of combination immunotherapy for a virtual murine cohort in a glioblastoma-immune dynamics model
Hannah G Anderson, Gregory P. Takacs, Jeffrey K. Harrison, et al.
Journal of Theoretical Biology (2024), pp. 111951-111951
Open Access
Hannah G Anderson, Gregory P. Takacs, Jeffrey K. Harrison, et al.
Journal of Theoretical Biology (2024), pp. 111951-111951
Open Access
Optimal control of combination immunotherapy in a glioblastoma-immune dynamics model
Hannah G. Anderson, Gregory P. Takacs, Jeffrey K. Harrison, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Hannah G. Anderson, Gregory P. Takacs, Jeffrey K. Harrison, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Clinical significance and potential mechanism of AEBP1 in glioblastoma
Chengcheng Wang, Huan Han, Fang Cheng, et al.
Journal of Neuropathology & Experimental Neurology (2024) Vol. 83, Iss. 12, pp. 1020-1029
Closed Access
Chengcheng Wang, Huan Han, Fang Cheng, et al.
Journal of Neuropathology & Experimental Neurology (2024) Vol. 83, Iss. 12, pp. 1020-1029
Closed Access